Summary
Lymphatic metastasis is an important mechanism in the spread of human cancer. During its course, tumor cells first penetrate the basement of membrane of the epithelium, in which they arise, and then the underlying connective tissue, carried partly by hydrostatic pressure. They enter the lymphatic partly by active movement, pass up the lymphatic trunk; they then settle and proliferate in the subcapsular sinus, penetrate its endothelium and proliferate and destroy the node. There are varied forms of immune response in the node and in human nodes often a complex fibrous and vascular response. The degree of lymphocytic response may be important for prognosis. The nodal reaction may be stimulated by release of antigens from the tumor.
One of the most studied animal models of lymphatic metastasis is that which occurs in the politeal node after injection of tumor into the footpad. This model has been used to show that tumor cells enter lymphatics through gaps in endothelium, probably between endothelial cells, and that lymph nodes can destroy small numbers of tumor cells. Local immunotherapy and chemotherapy can sterilize a lymph node of tumor cells; the modes of treatment used have included intralymphatic injection and encapsulation of chemotherapeutic agents in liposomes. Prior radiotherapy may accelerate metastasis possibly by making tumor cells shed into lymphatic vessels. Lymph nodes are rather poor barriers to tumor cells. The prognostic significance of lymph node metastasis varies within tumor type; if hematogenous metastasis is early, then the presecce of lymph node metastasis is of lesser prognostic significance. Lymph nodes can probably destroy only small numbers of tumor cells.
Tumor cell heterogeneity is of importance in many aspects of metastasis; while clonal variation may be of importance in determining lymph node metastasis, it is not yet clear how important this is, nor whether specific clones metastasize specifically to lymph nodes.
Lymphography is well established in diagnosis of lymphatic metastasis. A recent interesting development has been to inject antibodies labeled with a radioactive label, and image the label in lymph nodes with a gamma-camera. If anti-tumor antibodies are used in this way it may be possible to detect lymph node metastasis.
Within the expanding field of tumor metastasis, lymphatic metastasis needs much more attention, particularly in relation to the diagnosis and treatment of the lymphatic spread of human cancer.
Similar content being viewed by others
References
Zeidman I, Buss JM: Experimental studies on the spread of cancer in the lymphatic system. I. Effectiveness of the lymph node as a barrier to the passage of embolic tumor cells. Cancer Res (14): 403–405, 1954.
Van de velde CJH, Carr I: Lymphatic invasion and metastasis. Experientia (33): 837–884, 1977.
Carr I, Carr J: Experimental lymphatic invasion and metastasis. In: Weiss L, Gilbert HA, Ballon SC (eds) Lymphatic system metastasis. GK Hall, Boston, 1980, pp 41–73.
Carr I, Carr J: Experimental models of lymphatic metastasis. In: Liotta LA, Hart IR (eds) Tumor invasion and metastasis. Martinus Nijhoff, The Hague, 1982 pp 189–205.
Tarin D. Tissue interactions in carcinogenesis. Academic Press, London, New York, 1972, pp 227–289.
Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284 (5751): 67–68, 1980.
Casley-Smith JR: The functioning and interrelationships of blood capillaries and lymphatics. Experientia (32): 1–12, 1976.
Butler TP, Grantham FH, Gullino PM: Bulk transfer of fluid in the interstial compartment of mammary tumors. Cancer Res (35): 3084–3088, 1975.
Carr I: The pathologist's role in interpreting matastatic lymph node disease. In: Weiss L, Gilbert HA, Ballon SC (eds) Lymphatic system metastasis. GK Hall, Boston, 1980, pp 138–154.
Nime FA, Rosen PP, Thaler HT, Ashikari R, Urban JA: Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol (1): 25–30, 1977.
Tsakraklides V, Olson P, Kersey JH, Good A: Prognostic significance of the regional lymph node histology in cancer of the breast. Cancer (34): 1259–1267, 1974.
Tsakraklides E, Tsakraklides V, Ashikari H, Rosen PP, Siegal FP, Robbins GF, Good RA: In vitro studies of axillary lymph node cells in patients with breast cancer. J Natl Cancer Inst (54): 549–556, 1975.
Tsakraklides V, Wanebo HJ, Sternberg SS, Stearns M, Good RA: Prognostic evaluation of regional lymph node morphology in colorectal cancer. Am J Surg (129): 175–180, 1975.
Van Nagell JRJr, Donaldson ES, Parker JC, van Dyke AM, Wood EG: The prognostic significance of pelvic lymph node morphology in carcinoma of the uterine cervix. Cancer (39): 2624–2632, 1977.
Kaufman M, Wirth K, Scheurer J, Zimmerman A, Luseieti F, Stjernsward J: Immunomorphological lymph node changes in patients with operable bronchogenic squamous cell carcinoma. Cancer (39): 2371–2377, 1977.
Hirschl S, Black MM, Kwon CS: Ultrastructural characteristics of sinus histiocytic reaction in lymph nodes draining various stages of breast cancer. Cancer (38): 807–817, 1976.
Black MM, Kerpe S, Speere FD: Lymph node structure in patients with cancer of the breast. Am J. Pathol (29): 505–521, 1953.
McDivitt RW: Breast carcinoma. Hum Pathol (9): 3–21, 1978.
Deland FH, Goldenberg DM: In vivo radioimmunological lymphoscintigraphy in cancer. The implications of positive findings. J Can Assoc Radiol (33): 1, 4–9, 1982.
Pickren JW: Significance of occult metastases. A study of breast cancer. Cancer (14): 1266–1271, 1961.
Lee YTNM. Lymph node involvement in soft tissue and bone sarcomas. In: Weiss L, Gilbert HA, Ballon SC (eds) Lymphatic system metastasis. GK Hall, Boston, 1980, pp 410–433.
Carr I, McGinty F: Lymphatic metastasis and its inhibition, an experimental model. J. Pathol (113): 85–95, 1974.
Carr I, McGinty F, Norris P: The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumor. J. Pathol (118): 91–99, 1976.
Carr I, McGinty F: Neoplastic invasion and metastasis within the lymphoreticular system. In: Reichard S, Escobar M, Friedman H (eds) The reticuloendothelial system in health and disease: immunologic and pathologic aspects, Plenum Press, New York, 1976.
Carr J, Carr I, Dreher B, Betts K: Lymphatic metastasis: invasion of lymphatic vessels and efflux of tumor cells in the afferent popliteal lympha as seen in the Walker rat carcinoma. J. Pathol (132): 287–305, 1980.
Carr I, Carr J, Dreher B: Lymphatic metastasis of mammary adenocarcinoma: an experimental study in the rat with a brief review of the literature. Invasion Metastasis 1: 34–53, 1981.
Wallace AC, Josephson RL, Hollenberg NK: Observations on lymph node metastases. In: Grundmann E (ed) Cancer campaign. Gustav Fisher, New York, 1980, pp 83–99.
Wood P, Carr I: The quantitation of experimental lymph node metastasis. J Pathol (114): 85–88, 1974.
Van de Velde CJH, Meyer CJLM, Cornelisse CJ, Van der Velde EA, Van Putten LM, Zwaveling A. A morphologic analysis of lymph node responses to tumors of different immunogenicity. Cancer Res (38): 661–667, 1978.
Herman PG, Kim C-S, de Sousa MAB, Mellins HZ: Microcirculation of the lymph node with metastases. Am J Pathol (85): 333–348, 1976.
Hanna MGJr, Zbar B, Rapp HJ: Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. J Natl Cancer Inst (48): 1441–1455, 1972.
Zbar G, Hunter JT, Rapp HJ, Canti GF: Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG). J Natl Cancer Inst (6): 1163–1168, 1978.
Hanna MGJr, Peters LC: Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery. Cancer (42): 2613–2625, 1978.
Bogden AE, Esber HJ, Taylor DJ, Gray JH: Comparative study on the effects of surgery, chemotherapy and immunotherapy alone and in combination, on metastases of the 13762 mammary adenocarcinoma. Cancer Res (34): 1627–1731, 1974.
Kreider JW, Bartlett GL, Purnell DM: Suitability of rat mammary adenocarcinoma 13762 as a model for BCG immunotherapy. J Natl Cancer Inst (56): 797–802, 1976.
Kreider JW, Barlett GL, Purnell DM, Webb S: Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum. Cancer Res (38): 4522–4526, 1978.
Kreidler JW, Bartlett GL, Purnell DM: Immunotherapy of post operative metastases of 13762A rat mammary adenocarcinoma. Comparative effectiveness of BCG substrains and methods of preparation. Cancer (46): 500–507, 1980.
Van de Velde CJH, Van Putten LM, Zwaveling A: Effects of regional lymphadenectomy and adjuvant chemotherapy on metastasis and survival in rodent tumour models. Eur J Cancer (13): 883–895, 1977.
Takahashi T, Koni K, Yamaguchi T, Watanabe S, Majima S. Enhancement of chemotherapeutic effect on lymph node metastasis by anticancer agents in fat emulsion. Gann Monogr Cancer Res (20): 195–206, 1977.
Kaledin VI, Matienko NA, Nikolin VP, Gruntenko YV, Budker VG: Intralymphatic administration of lipsomeencapsulated drugs to mice. Possibility for the suppression of the growth of tumor metastases in the lymph nodes. J Nat Cancer Inst (66): 881–887, 1981.
Khato J, Priester ER, Siebec SM: Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. Cancer Treat Rep (66): 517–527, 1982.
Carr J, Dreher B, Carr I: Lymphatic metastasis; lymphangiochemotherapy of mammary cancer: ascitic form of rat mammary adenocarcinoma 13762. Clin Exp Metastasis (1): 29–38, 1983.
Edwards JM, Pheils PJ: Endolymphatic isotope and BCG in the management of malignant melanoma. Aust NZ J Surg (48): 40–49, 1978.
Juillard GJF, Boyer PJJ: intralymphatic immunization: current status. Eur J Cancer (13): 439–440, 1977.
Ariyan S, Kirkwood JM, Mitchell MS, Nordlund JJ, Lerner AB, Papac RJ: Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma od the extremities. Surgery (92): 459–463, 1982.
Courdi A, Malaise EP: Effect of size of lymph node metastases on the radiation response: influence of misonidazole. Radiat Res (83): 723–731, 1980.
Rappaport DS, Brown JM: Influence of localized preinoculation irradiation of the foot on lymphatic metastasis from a primary tumor growing in the foot. Radiat Res (78): 198–121, 1979.
Rappaport DS, Brown JM: A study of the mechanism by which localized preinoculation enhances the rate of lymphatic spread. Radiat Res (83): 566–578, 1980.
Van den Brenk HAS, Crowe MC, Stone MG: Reactions of the tumor bed to lethally irradiated tumor cells, and the Révész effect. Br J Cancer (36): 94–104.
Kodama T, Gotahda E, Takeichi N, Kuzumaki N, Kobayashi H: Histopathology of immunologic regression of tumor metastasis in the lymph nodes. J Natl Cancer Inst (52): 931–939, 1974.
Fisher B, Fisher ER: Transmigration of lymph nodes by tumor cells. Science (152): 1397–1398, 1966.
Hewitt HB, Blake ER: Quantitative studies of translymphnodal passage of tumor cells naturally disseminated from a non-immunogenic murine squamous carcinoma. Br J Cancer (31): 25–35, 1975.
Hewitt HB, Blake ER: Further studies of the relationship between lymphatic dissemination and lymph nodal metastasis in non-immunogenic murine tumours. Br J Cancer (35): 415–419, 1977.
Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet (152): 765–772, 1981.
Sugarbaker EV, Weingrad DN, Roseman JM: Observations on cancer metastasis in man. In: Liotta LA, Hart IR (eds) Tumor invasion and metastasis. Martinus Nijhoff, The Hague, pp 427–465.
Stoker TAM: The effect of cortisone therapy and limb exercise on the dissemination of cancer via the lymphatic system. Br J Cancer (23): 136–140, 1979.
Stoker TAM: The effect of cortisone therapy and limb exercise on the retention of tumour cells by the regional lymph node. Br J Cancer (23): 136–140, 1969.
Zeidman I: Fate of circulating tumor cells. III. Comparison of metastatic growth produced by tumor cell emboli in veins and lymphatics. Cancer Res (25): 324–327, 1965.
Ludwig J, Titus JL: Experimental tumor cell emboli in lymph nodes. Arch Pathol (84): 304–311, 1967.
Crile GJr, Isbister W, Deodhar SD: Demonstration that large metastases in lymph nodes disseminate cancer cells to blood and lungs. Cancer (28): 657, 1971.
Fidler IJ, Hart IR: Biological diversity in metastatic neoplasms: origins and implications. Science (217): 998–1003, 1982.
Weiss L: Metastasis: differences between cancer cells in primary and secondary tumors. Pathobiol Annu (10): 51–81, 1980.
Fidler IJ, Hoover HC: Lymph node and visceral metastasis of cloned murine fibrosarcoma cell lines. In: Weiss L, Gilbert HA, Ballon SD (eds) Lymphatic system metastasis. GK Hall, Boston, 1980, pp 80–90.
Neri A, Welch D, Kawaguchi T, Nicolson GL: Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. J Natl Cancer Inst (68): 507–517, 1982.
Boak JL, Agwunobi TC. A study of technetium-labelled sulphide colloid uptake by regional lymph nodes draining tumour-bearing area. Br J Surg (65): 374–378, 1978.
Agwunobi TC, Boak JL: Diagnosis of malignant breast disease by axillary lymphoscintigraphy: a preliminary report. Br J Surg (65): 379–383, 1978.
Weinstein JN, Parker RJ, Keenan AM, Dower SK, Morse HC, Sieber SM: Monoclonal antibodies in the lymphatics: toward the diagnosis and therapy of tumor metastases. Science (218): 1334–1337, 1982.
Carr I, Orr FW: Invasion and metastasis. Can Med Assoc J (128): 1164–1167, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carr, I. Lymphatic metastasis. Cancer Metast Rev 2, 307–317 (1983). https://doi.org/10.1007/BF00048483
Issue Date:
DOI: https://doi.org/10.1007/BF00048483